All In MedTech

Device Trial Radar · NCT07171060

Laplace Early Feasibility Study - Canada

Laplace Outside the US (OUS) Early Feasibility Study (EFS) Canada

Last checked: Nov 20, 2026Latest source record: Jul 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

15

Planned (sponsor's estimate)

Start

Jun 18, 2024

Primary completion

Dec 30, 2027

Study completion Jan 1, 2032

Sponsor

Lead sponsor
Laplace Interventional, IncNot on our public-company list
Sponsor type
Industry
First posted
Sep 12, 2025

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 60 years, up to 90 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The objective of the study is to assess the safety and technical feasibility of the Laplace Transcatheter Tricuspid Valve Replacement (TTVR) System

Conditions

  • Tricuspid Regurgitation

Interventions

  • Laplace TTVR SystemDevice

    Transcatheter Tricuspid Valve Replacement (TTVR) System for the treatment of severe, symptomatic tricuspid regurgitation

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Technical successTime frame: During procedure

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • University of Ottawa Heart Institute

    Ottawa, Ontario, Canada · Recruiting

  • Sunnybrook Research Institute

    Toronto, Ontario, Canada · Recruiting

  • St. Michael's Hospital

    Toronto, Ontario, Canada · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.